Ipamorelin and LL-37 Interaction

Synergistic
Mechanism-based 47% confidence

Ipamorelin and LL-37 have a synergistic interaction with 47% confidence. Ipamorelin and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

LL-37

Human Cathelicidin | Antimicrobial Peptide

Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..

Half-life: Short (rapid proteolytic degradation) Typical dose: 0.5-1.6 mg/mL topical gel or 100-150 mcg injectable immune, healing
View full profile

Combined Organ Load

Brain
low
GI Tract
low
Pituitary
low
Blood Vessels
low

Frequently Asked Questions

Can I take Ipamorelin with LL-37?

Yes, Ipamorelin and LL-37 can generally be taken together. Ipamorelin and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Ipamorelin and LL-37 safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between Ipamorelin and LL-37?

Ipamorelin and LL-37 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Ipamorelin and LL-37?

Ipamorelin has a half-life of ~2 hours and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Ipamorelin vs LL-37

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.